Phenotypic analyses using CHI3L1 knockout (KO) mice, overexpression models, and anti-CHI3L1 antibody interventions in both acute and chronic inflammatory conditions, such as allergic inflammation, colitis, and pulmonary fibrosis, have yielded critical insights [25,26,27]. This evidence concerns the gene CHI3L1 and pulmonary fibrosis.